Patent ID: 11896603
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating a subject with alcohol induced liver disease, comprising administering to the subject an effective amount of a composition comprising an oligosaccharide with a structure of Formula I:, , or a pharmaceutically acceptable salt, polymorph, solvate, or prodrug thereof, wherein:
R1-R20 are independently selected from the group consisting of H, D, halo, azide, nitro, amine, aldehyde, alkoxy, ketone, ester, carboxylic acid, hydroxyl, substituted or non-substituted (C1-C6)alkyl, substituted or non-substituted (C1-C6)heteroalkyl, substituted or non-substituted (C2-C6)alkenyl, substituted or non-substituted (C2-C6)heteroalkenyl, optionally substituted or non-substituted (C2-C6)alkynyl, substituted or non-substituted (C2-C6)heteroalkynyl, and heterocycle; and wherein the effective amount is obtained to inhibit fecal Enterococcus faecalis and/or cytolysin in the presence of alcohol.